PolyPeptide Group (Hangzhou) (revision 12)
Old revision·16:42, 30 Oct 2025·ReportReaderRilla
| PolyPeptide Group (Hangzhou) Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | PolyPeptide Group (Hangzhou) Co., Ltd. |
| Trading name | PPG |
| Other designations | PolyPeptide, PolyPeptide Group, 多肽集团 |
| Identity | |
| Founded | 2006 |
| Headquarters | Hangzhou, Zhejiang, China |
| Industry | Research-compound supply |
| Official site | Visit PPG at polypeptidegroup.net |
| Products and documentation | |
| Product scope | solid-phase peptide synthesis, research peptides, raw materials and custom sequences |
| Catalogue size | 350+ listings (self-reported) |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| Organisation infobox · conventions | |
PolyPeptide Group (Hangzhou) Co., Ltd. (trading as PPG; polypeptidegroup.net) is a solid-phase peptide synthesis operation trading as PPG from Hangzhou, Zhejiang, China, incorporated in 2006 and supplying research peptides and raw materials with batch documentation that reproduces the chromatogram behind each purity figure.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Incorporated in Hangzhou in 2006, the organisation predates the current research-peptide market and describes a business built on solid-phase synthesis carried out on its own lines rather than on catalogue distribution.[1] Hangzhou sits in the Yangtze River Delta manufacturing belt; the registry record establishes the entity and the date and nothing beyond them.[1]
The organisation's own material describes in-house Fmoc solid-phase synthesis with purification and lyophilisation on site. That is a self-published characterisation and is recorded here as one: nothing available to this wiki establishes the manufacturing arrangements behind it, and a registered business scope is a licensing fact rather than a capability finding.[2][1]
The documentary base is the registry record, the organisation's own material and purchaser-submitted test reports. No independent coverage has been identified, which is a characteristic of the sector rather than of this entity.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe vialled lyophilised material arriving with a batch-specific certificate naming a lot, and across the submitted set the lot string on the certificate has corresponded to the vial label and to the commercial documentation.[5] That correspondence is a minimum requirement rather than an achievement, and it is recorded only because traceability fails often enough elsewhere in this sector to make its absence the more common finding.
The feature that distinguishes the submitted certificates from others held by this wiki is the reproduction of the chromatogram itself. Where a certificate ordinarily reports an area percent figure and asks the reader to accept it, the certificates in this set print the trace the figure was integrated from, with the gradient table, the column identifier and the detection wavelength beside it.[5] A reader competent to read a chromatogram can therefore inspect baseline placement and integration limits rather than take the figure on trust. The limit of that is worth stating precisely: a printed trace evidences the integration of the injection it depicts. It does not establish that any particular vial was filled from the material that injection was drawn from, and no source available here bridges that gap.[5]
Peptide content is reported separately from area percent, water is determined by Karl Fischer titration with the method named, and counter-ion identity and content are given as a figure with its unit. Reports describe those three fields as present on issue rather than supplied on request.[5] Together they are what allow delivered peptide mass to be calculated from the fill; separately, none of them is sufficient.
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide, retatrutide | Batch certificate with reproduced chromatogram, gradient table and mass confirmation |
| Research peptides | BPC-157, TB-500, growth-hormone secretagogues | Certificate with purity, appearance, water and reproduced trace |
| Custom synthesis | Sequences quoted individually | Certificate with mass confirmation and stated analytical conditions |
| Injectable preparations | Oil-carrier presentations | Certificate with purity and carrier identity |
| Raw materials | Bulk powders | Certificate with purity; specification sheet on request |
Listings and their descriptions are taken from the organisation's own catalogue and are recorded as self-published.[2] The count above the table is the organisation's own figure; this wiki has not enumerated the catalogue and does not adopt the number as a finding.
References
- ^ a b c d National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b c Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b c d Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.